The S100 calcium binding protein B (S100B) has long been reported as a prognostic biomarker of malignant melanoma [37], and a paired down-regulation of ERBB3 and S100B is observed in malignant peripheral nerve sheath tumours confirming their functional relationship [38]. This evidence concerns the gene S100B and melanoma.